open access

Vol 67, No 3 (2016)
Original papers
Published online: 2016-06-30
Submitted: 2015-01-22
Accepted: 2015-03-30
Get Citation

Serotonin and melatonin secretion in postmenopausal women with eating disorders

Cezary Chojnacki, Ewa Walecka-Kapica, Aleksandra Błońska, Katarzyna Winczyk, Agnieszka Stępień, Jan Chojnacki
DOI: 10.5603/EP.2016.0012
·
Endokrynologia Polska 2016;67(3):299-304.

open access

Vol 67, No 3 (2016)
Original papers
Published online: 2016-06-30
Submitted: 2015-01-22
Accepted: 2015-03-30

Abstract

Introduction: Postmenopausal women manifest emotional disorders associated with an increase in appetite. The aim of the study was to assess the serotonin and melatonin secretion and metabolism in postmenopausal women in relation to eating disorders.

Material and methods: Sixty postmenopausal women and 30 women without hormonal disturbances were enrolled into the study and divided into three groups: group I (control) – women without menstrual disorders, group II — postmenopausal women without appetite disorders and change in body weight, and group III — postmenopausal women with increased appetite and weight gain. Serum melatonin, serotonin, urinary 6-sulfatoxymelatonin (aMT6s), and 5-hydroxyindoleacetic acid (5-HIAA) excretion were measured.

Results: Serum serotonin and melatonin levels in groups II and III were lower compared to group I. Urinary 5-HIAA and aMT6s excretion was lower in overweight women. In group III the correlation between the serum level of serotonin, melatonin, and BMI was negative; a high statistical significance was found between BMI and urinary aMT6s excretion.

Conclusions: Melatonin supplementation and use of drugs modulating the serotonin homeostasis together with female hormones have a beneficial effect in complex treatment of disorders of eating in postmenopausal women. (Endokrynol Pol 2016; 67 (3): 299–304)

Abstract

Introduction: Postmenopausal women manifest emotional disorders associated with an increase in appetite. The aim of the study was to assess the serotonin and melatonin secretion and metabolism in postmenopausal women in relation to eating disorders.

Material and methods: Sixty postmenopausal women and 30 women without hormonal disturbances were enrolled into the study and divided into three groups: group I (control) – women without menstrual disorders, group II — postmenopausal women without appetite disorders and change in body weight, and group III — postmenopausal women with increased appetite and weight gain. Serum melatonin, serotonin, urinary 6-sulfatoxymelatonin (aMT6s), and 5-hydroxyindoleacetic acid (5-HIAA) excretion were measured.

Results: Serum serotonin and melatonin levels in groups II and III were lower compared to group I. Urinary 5-HIAA and aMT6s excretion was lower in overweight women. In group III the correlation between the serum level of serotonin, melatonin, and BMI was negative; a high statistical significance was found between BMI and urinary aMT6s excretion.

Conclusions: Melatonin supplementation and use of drugs modulating the serotonin homeostasis together with female hormones have a beneficial effect in complex treatment of disorders of eating in postmenopausal women. (Endokrynol Pol 2016; 67 (3): 299–304)

Get Citation

Keywords

serotonin; melatonin; postmenopausal women; disorders of eating

About this article
Title

Serotonin and melatonin secretion in postmenopausal women with eating disorders

Journal

Endokrynologia Polska

Issue

Vol 67, No 3 (2016)

Pages

299-304

Published online

2016-06-30

DOI

10.5603/EP.2016.0012

Bibliographic record

Endokrynologia Polska 2016;67(3):299-304.

Keywords

serotonin
melatonin
postmenopausal women
disorders of eating

Authors

Cezary Chojnacki
Ewa Walecka-Kapica
Aleksandra Błońska
Katarzyna Winczyk
Agnieszka Stępień
Jan Chojnacki

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl